<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04923685</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-300006024</org_study_id>
    <nct_id>NCT04923685</nct_id>
  </id_info>
  <brief_title>MicroRNA Correlates of Childhood Maltreatment and Suicidality</brief_title>
  <official_title>MicroRNA Correlates of Childhood Maltreatment and Suicidality</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a research study to find out if childhood trauma and stress are associated with&#xD;
      depression or suicidal risk. The study will assess the effects of both short-term and&#xD;
      long-term stress on biomarker (e.g. miRNA [MiRNA]) levels. miRNAs are a type of RNA (genetic&#xD;
      material that is translated into protein) that are found in throughout the body and blood.&#xD;
      They are called microRNA because their size is much smaller than typical RNA molecules.&#xD;
      miRNAs are highly responsive to environment. This responsiveness is reflected in their&#xD;
      expression in individuals who are affected by environment such as stress. The investigators&#xD;
      are gathering genetic material, including DNA and RNA, from each participant. The RNA will be&#xD;
      taken from the small vesicles and cells in the participant's blood and analyzed. The vesicles&#xD;
      are small objects that occur normally in the blood and that contain RNA. This information may&#xD;
      help us to understand the cause of mental illness and to improve medical and psychiatric care&#xD;
      in the future. There will be 450 participants enrolled in this study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of the study is to determine if the relationship between a history of childhood&#xD;
      maltreatment (CM) and suicide risk is associated with alterations in the expression and&#xD;
      epigenetic modification of specific microRNAs (miRNAs), thereby providing a molecular&#xD;
      signature of suicide risk in people with CM. miRNAs are short regulatory RNAs that transduce&#xD;
      environmental events into changes in protein synthesis in cells. The environment can induce&#xD;
      permanent changes in miRNA expression. Aim 1 is to identify a set of neural-derived exosomal&#xD;
      miRNAs that are associated with the interaction of suicidality and CM. Aim 2 is to examine&#xD;
      whether an acute experimental stressor, the Trier Social Stress Test (TSST), impacts the&#xD;
      expression of these miRNAs in suicidal patients with and without CM. Aim 3 will examine&#xD;
      potential mechanisms by which altered miRNAs may contribute to CM-associated suicidal&#xD;
      behavior. Aim 4 will examine if changes in CM-associated miRNAs are explained by&#xD;
      modifications in their DNA methylation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 26, 2021</start_date>
  <completion_date type="Anticipated">September 2025</completion_date>
  <primary_completion_date type="Anticipated">September 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>MicroRNA response to stress</measure>
    <time_frame>24 hours</time_frame>
    <description>MiRNAs methylation levels will be examined</description>
  </primary_outcome>
  <number_of_groups>6</number_of_groups>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Major Depressive Disorder</condition>
  <condition>Suicidal Ideation</condition>
  <arm_group>
    <arm_group_label>MDD with elevated CM and suicidality scores</arm_group_label>
    <description>Major Depressive Disorder with elevator childhood maltreatment and suicidality scores.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MDD with CM history but lower suicidality</arm_group_label>
    <description>Major Depressive disorder with childhood maltreatment history but lower suicidality scores.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MDD without CM but with elevated suicidality</arm_group_label>
    <description>Major Depressive Disorder without childhood maltreatment, but with elevated suicidality scores.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MDD without CM but with lower suicidality</arm_group_label>
    <description>Major Depressive Disorder without childhood maltreatment but with lower suicidality scores.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls with CM history</arm_group_label>
    <description>Healthy controls with childhood maltreatment history,</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy controls without CM history</arm_group_label>
    <description>Healthy controls without childhood maltreatment history.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Trier Social Stress Test</intervention_name>
    <description>The TSST is a standardized test to induce acute psychological stress in humans. Participants will abstain from caffeine for 12 hours and nicotine for 2 hours prior to the test. An IV butterfly catheter will be placed in an arm vein and flushed with saline. Participants will rest for 15 minutes. A 10ml baseline blood sample will be drawn. They will perform the TSST task and then have 10ml of blood drawn at 0, 15, 30, 60, and 90 minutes post-TSST.</description>
    <arm_group_label>Healthy controls with CM history</arm_group_label>
    <arm_group_label>Healthy controls without CM history</arm_group_label>
    <arm_group_label>MDD with CM history but lower suicidality</arm_group_label>
    <arm_group_label>MDD with elevated CM and suicidality scores</arm_group_label>
    <arm_group_label>MDD without CM but with elevated suicidality</arm_group_label>
    <arm_group_label>MDD without CM but with lower suicidality</arm_group_label>
    <other_name>TSST</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood and urine collection&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        People between the ages of 18 and 60 with either a history of Major Depressive Disorder or&#xD;
        no lifetime history of any major mental illness.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age 18-60&#xD;
&#xD;
          2. Physically healthy&#xD;
&#xD;
          3. Willing and able to provide informed consent&#xD;
&#xD;
        5. Diagnosis of MDD or No history of mental illness&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnancy or lactation (women of reproductive potential must have a negative urine&#xD;
             pregnancy screen)&#xD;
&#xD;
          2. Post-partum state (being within 2 months of delivery or miscarriage)&#xD;
&#xD;
          3. Homicide risk as determined by clinical interview&#xD;
&#xD;
          4. A lifetime history of psychotic disorder&#xD;
&#xD;
          5. Any history of dissociation or dissociative disorder&#xD;
&#xD;
          6. Bipolar disorder&#xD;
&#xD;
          7. Pervasive developmental disorder&#xD;
&#xD;
          8. Cognitive disorder&#xD;
&#xD;
          9. Cluster A personality disorder&#xD;
&#xD;
         10. Borderline personality disorder&#xD;
&#xD;
         11. Anorexia nervosa&#xD;
&#xD;
         12. Alcohol or drug dependence (except nicotine and caffeine) within the last month or the&#xD;
             use of any hallucinogen (except cannabis), including phencyclidine in the last month&#xD;
             (NOTE that a positive UDS is not exclusionary except for hallucinogens,&#xD;
             methamphetamine, or cocaine. People presenting intoxicated with alcohol may be&#xD;
             included when a Breathalyzer test (Alco-Sensor IV) is negative as long as there is no&#xD;
             history of recent dependence.&#xD;
&#xD;
         13. Recent myocardial infarction&#xD;
&#xD;
         14. Unstable angina&#xD;
&#xD;
         15. Active neoplasm in the past 6 months&#xD;
&#xD;
         16. Immunosuppressive or corticosteroid therapy within the last month, with the following&#xD;
             exceptions: any inhaled, intranasal, topical or vaginal corticosteroids are allowed.&#xD;
&#xD;
         17. Chemotherapy&#xD;
&#xD;
         18. Head injury with loss of consciousness in the past 6 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yogesh Dwivedi, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Allison Stewart, BA</last_name>
    <phone>256-551-4428</phone>
    <email>allisonstewart@uabmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Richard C Shelton, MD</last_name>
    <phone>256-551-6630</phone>
    <email>rcshelton@uabmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Alexander</last_name>
      <phone>205-934-2484</phone>
      <email>lalexander@uabmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UAB Huntsville Regional Medical Campus</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allison M Stewart, BA</last_name>
      <phone>256-551-4431</phone>
      <email>allisonstewart@uabmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jessica Weed, BA</last_name>
      <phone>256-551-4687</phone>
    </contact_backup>
    <investigator>
      <last_name>Yogesh Dwivedi, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Richard C Shelton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 2, 2021</study_first_submitted>
  <study_first_submitted_qc>June 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 11, 2021</study_first_posted>
  <last_update_submitted>June 30, 2021</last_update_submitted>
  <last_update_submitted_qc>June 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Yogesh Dwivedi, PhD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Depression</keyword>
  <keyword>Suicidal Ideation</keyword>
  <keyword>Suicidality</keyword>
  <keyword>Healthy Control</keyword>
  <keyword>Depression and Anxiety</keyword>
  <keyword>Childhood Maltreatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
    <mesh_term>Suicidal Ideation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

